Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
Published inJournal of acquired immune deficiency syndromes, vol. 57, no. 1, p. 24-31
Publication date2011
Abstract
Keywords
- Adult
- Anti-HIV Agents/administration & dosage
- Cohort Studies
- Female
- HIV Infections/blood/drug therapy/virology
- HIV-1/growth & development
- Humans
- Logistic Models
- Male
- Middle Aged
- Proportional Hazards Models
- Pyrrolidinones/administration & dosage
- RNA, Viral/blood
- Reverse Transcriptase Inhibitors/administration & dosage
- Salvage Therapy/methods
Affiliation entities
Research groups
Citation (ISO format)
SCHERRER, Alexandra U et al. Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. In: Journal of acquired immune deficiency syndromes, 2011, vol. 57, n° 1, p. 24–31. doi: 10.1097/QAI.0b013e318211925e
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25321
- DOI : 10.1097/QAI.0b013e318211925e
- PMID : 21283013
Journal ISSN1525-4135